Scinai Immunotherapeutics (SCNI) Receivables - Net (2015 - 2026)

Scinai Immunotherapeutics has disclosed Receivables - Net across 11 years of filings, most recently posting $74000.0 for Q2 2026.

• In Q2 2026, Receivables - Net fell 46.76% year-over-year to $74000.0; the TTM figure through Jun 2026 stood at $74000.0 (down 46.76% YoY), while the FY2025 annual figure was $73000.0, down 12.05% from the prior year.
• Receivables - Net came in at $74000.0 for Q2 2026 at Scinai Immunotherapeutics, down from $150000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $202000.0 in Q3 2022 to a low of $73000.0 in Q4 2025.
• Average Receivables - Net over 4 years is $133500.0, with a median of $129500.0 recorded in 2024.
• Year-over-year, Receivables - Net tumbled 93.22% in 2022 and advanced 16.81% in 2025.
• Over 4 years, Receivables - Net stood at $202000.0 in 2022, then tumbled by 58.91% to $83000.0 in 2024, then declined by 12.05% to $73000.0 in 2025, then advanced by 1.37% to $74000.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $74000.0 in Q2 2026, $150000.0 in Q1 2026, and $73000.0 in Q4 2025.